Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 734-759

  Salek, M S ^a   Jung, S ^a   Brincat Ruffini, L A ^a   MacFarlane, L ^b   Lewis Jones, M S ^b   Basra, M K A ^c   Finlay, A Y ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT;

CHILDREN DERMATOLOGY LIFE QUALITY INDEX; CONSTRUCT VALIDITY; CONTENT VALIDITY; HEALTH SURVEY; HUMAN; MEDICAL LITERATURE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE INDEX; REVIEW; SKIN DISEASE; TEST RETEST RELIABILITY; TOPICAL TREATMENT;

ADMINISTRATION, ORAL; CHILD; CULTURE; DERMATOLOGIC AGENTS; HEALTH STATUS INDICATORS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TRANSLATIONS; WORLD HEALTH;

EID: 84885597920     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12437     Document Type: Review

References (128)

1. Lewis-Jones MS, Finlay AY,. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942-9.
2. Holme SA, Man I, Sharpe SL, et al,. The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-90.
3. Waters A, Sandhu D, Beattie P, et al,. Severity stratification of Children's Dermatology Life Quality Index (CDLQI) scores. Br J Dermatol 2010; 163 (Suppl. 1): 121.
4. Rehal B, Armstrong A,. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PloS One 2011; 6: e17520.
5. Walker N, Lewis-Jones MS,. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol 2006; 20: 45-50.
6. Basra MKA, Fenech R, Gatt RM, et al,. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
7. Ho RCM, Giam YC, Ng TP, et al,. The influence of childhood atopic dermatitis on the health of mothers and its impact on Asian families. Pediatr Allergy Immunol 2010; 21: 501-7.
8. Bodemer C, Bourrat E, Mazereeuw-Hautier J, et al,. Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis. Br J Dermatol 2011; 165: 1087-94.
9. Finlay AY, Basra MKA,. DLQI and CDLQI scores should not be combined. Br J Dermatol 2012; 167: 453-4.
10. Valenzuela F, Silva P, Valdés MP, Papp K,. Epidemiology and quality of life of patients with psoriasis in Chile. Actas Dermosifiliogr 2011; 102: 810-16.
11. Schuttelaar ML, Vermeulen KM, Drukker N, Coenraads PJ,. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol 2010; 162: 162-70.
12. Schuttelaar ML, Vermeulen KM, Coenraads PJ,. Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol 2011; 165: 600-11.
13. Jankovic̈ S, Vukic̈evic̈ J, Djordjevic̈ S, et al,. Quality of life among schoolchildren with acne: results of a cross-sectional study. Indian J Dermatol Venereol Leprol 2012; 78: 454-8.
14. Jankovic̈ S, Vukic̈evic̈ J, Djordjevic S, et al,. The Cardiff Acne Disability Index (CADI): linguistic and cultural validation in Serbian. Qual Life Res 2013; 22: 161-6.
15. Streiner DL, Norman GR,. Health Measurement Scales-A Practical Guide to their Development and Use, 2nd edn. Oxford: Oxford University Press, 1995.
16. Streiner DL, Norman GR,. Health Measurement Scales: A Practical Guide to their Development and Use, 3rd edn. Oxford: Oxford University Press, 2003.
17. Hattie J,. Methodology review: assessing unidimensionality of tests and items. Applied Psychological Measurements 1985; 9: 139-64.
18. Balci DD, Sangün O, Inandi T,. Cross validation of the Turkish version of Children's Dermatology Life Quality Index. J Turk Acad Dermatol 2007; 1: 71402a.
19. Angoff WH,. Perspectives on differential item functioning methodology. In: Differential Item Functioning (, Holland PW, Wainer H, eds). Hillside, NJ: Lawrence Erlbaum Associates, 1993; 3-23.
20. Streiner DL, Norman GR,. Health Measurement Scales: A Practical Guide to their Development and Use, 4th edn. New York: Oxford Medical Publications, 2008.
21. Arkachaisri T, Vilaiyuk S, Li S, et al,. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress towards development of localized scleroderma outcome measures. J Rheumatol 2009; 36: 2819-29.
22. Oostveen AM, De Jager MEA, Van de Kerkhof PCM, et al,. The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry. Br J Dermatol 2012; 167: 145-9.
23. Dauden E, Sanchez-Perez J, Prieto M, Roset M,. Validation of the Spanish version of the Itch Severity Scale: the PSEDA study. Actas Demosifiliogr 2011; 102: 527-36.
24. Solans M, Pane S, Estrada M-D, et al,. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value in Health 2008; 11: 742-62.
25. Neri E, Agostini F, Gremigni P, et al,. Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. J Invest Dermatol 2012; 132: 2534-43.
26. Ramirez-Anaya M, Macias ME, Velazquez-Gonzalez E,. Validation of a Mexican Spanish version of the Children's Dermatology Life Quality Index. Pediatr Dermatol 2010; 27: 143-7.
27. Guillemin F, Bombardier C, Beaton D,. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.
28. Cardiff University Department of Dermatology and Wound Healing. Children's Dermatology Life Quality Index CDLQI: Different Language Versions. Available at: http://www.dermatology.org.uk/quality/cdlqi/quality-cdlqi- languages.html (last accessed 20/07/2013).
29. Jaeschke R, Singer J, Guyatt GH,. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15.
30. Langley RG, Paller AS, Hebert AA, et al,. Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol 2011; 64: 64-70.
31. Paller AS, Siegfried EC, Langley RG, et al,. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008; 358: 241-51.
32. Camfferman D, Kennedy JD, Gold M, et al,. Eczema, sleep and behaviour in children. J Clin Sleep Med 2010; 6: 581-8.
33. Slattery MJ, Essex MJ, Paletz EM, et al,. Depression, anxiety and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 2011; 128: 668-71.
34. Schwartz R, Sepúlveda JE, Quintana T,. Possible role of psychological, environmental factors in the genesis of childhood vitiligo. Rev Med Chil 2009; 137: 53-62 (in Spanish).
35. Chernyshov PV,. Creation and cross-cultural adaptation of Ukrainian versions of questionnaires for assessment of quality of life of children with atopic dermatitis and their families. Lik Sprava 2008; 1-2: 124-8 (in Ukrainian).
36. Witt CM, Brinkhaus B, Pach D,. Homeopathic versus conventional therapy for atopic eczema in children: medical and economic results. Dermatology 2009; 219: 329-40.
37. Brown S, Reynolds NJ,. Atopic and non-atopic eczema. BMJ 2006; 332: 584-8.
38. Santana MJ, Feeny D,. IHE Report: The Importance of Measuring Health-Related Quality of Life. Edmonton: Institute for Health Economics, 2008.
39. Finlay AY,. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998; 17: 291-6.
40. Clayton TH, Clark SM, Britton J, et al,. A comparative study of the Children's Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria. J Eur Acad Dermatol Venereol 2007; 21: 1436-7.
41. Basra M, Salek S, Taweer Z, et al,. Refinement and validation of teenager's quality of life questionnaire (T-QoL). J Invest Dermatol 2011; 131 (Suppl. 2): 50.
42. Smidt AC, Lai JS, Cella D, et al,. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010; 146: 865-9.
43. Lewis-Jones MS, Finlay AY, Dykes PJ,. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001; 144: 104-10.
44. Jørgensen KM, Jemec GBE,. Evaluating PRISM (Pictorial Representation of Illness and Self Measure) as a measure of life quality for children with skin diseases. Eur J Pediat Dermatol 2011; 21: 135-42.
45. Chamlin SL, Cella D, Frieden IJ, et al,. Development of the childhood atopic dermatitis impact scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005; 125: 1106-11.
46. Dodington SR, Basra MKA, Finlay AY, et al,. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol 2013; 169: 31-46.
47. Aziah MS, Rosnah T, Mardziah A, Norzila MZ,. Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia 2002; 57: 329-39.
48. Chuh AA,. Validation of a Cantonese version of the Children's Dermatology Life Quality Index. Pediatr Dermatol 2003; 20: 479-81.
49. Maksimovic NA, Jankovic S, Marinkovic J, et al,. Health-related quality of life in patients with atopic dermatitis. J Dermatol 2012; 39: 42-7.
50. Harper JI, Ahmed I, Barclay G, et al,. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000; 142: 52-8.
51. Njoo MD, Bos JD, Westerhof W,. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-53.
52. Shum RW, Lawton S, Williams HC, et al,. The British Association of Dermatologists audit of atopic eczema management in secondary care. Phase 3: audit of service outcome. Br J Dermatol 2000; 142: 721-7.
53. Drake L, Prendergast M, Maher R, et al,. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44: S65-S72.
54. Chinn DJ, Poyner T, Sibley G,. Randomized controlled trial of a single dermatology nurse consultant in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432-9.
55. Ben-Gashir MA, Seed PT, Hay RJ,. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004; 150: 284-90.
56. Leo HL, Bender BG, Leung SB, et al,. Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. J Allergy Clin Immunol 2004; 114: 691-3.
57. Won C, Seo P, Park Y, et al,. A multicenter trial of the efficacy and safety of 0·03% tacrolimus ointment for atopic dermatitis in Korea. J Dermatolog Treat 2004; 15: 30-4.
58. Agarwal S, Ramam M, Sharma VK, et al,. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. Br J Dermatol 2005; 153: 163-6.
59. Berth-Jones J, Arkwright PD, Marasovic D, et al,. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2006; 36: 1115-21.
60. Bryemo G, Rod G, Carlsen KH,. Effect of climatic change in children with atopic eczema. Allergy 2006; 61: 1403-10.
61. Giordano-Labadie F, Cambazard F, Guillet G, et al,. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis. J Dermatolog Treat 2006; 17: 78-81.
62. Grillo M, Gassner L, Marshman G, et al,. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol 2006; 23: 428-36.
63. Holm EA, Wulf HC, Stegmann H, Jemec GBE,. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 54: 719-25.
64. Langan SM, Bourke JF, Silcocksand P, Williams HC,. An exploratory prospective observational study of environmental factors exacerbating atopic eczema in children. Br J Dermatol 2006; 154: 979-80.
65. ®, SDZ ASM 981): impact on quality of life and health-related quality of life. J Eur Acad Dermatol Venereol 2006; 20: 248-54.
66. Sunderkotter C, Weiss JM, Bextermoller R, et al,. Post-marketing surveillance on treatment of 5665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life. J Dtsch Dermatol Ges 2006; 4: 301-6.
67. Hon KLE, Leung TF, Ng PC, et al,. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-63.
68. Shaw M, Morrell DS, Goldsmith LA,. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). Pediatr Dermatol 2008; 25: 19-24.
69. Brothers S, Asher MI, Jaksic M, Stewart AW,. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. Clin Exp Dermatol 2009; 34: 770-5.
70. Kubota Y, Yoneda K, Nakai K, et al,. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. J Am Acad Dermatol 2009; 60: 212-17.
71. Hon KL, Wang SS, Lau Z, et al,. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J 2011; 17: 132-6.
72. Taieb C, Sibaud V, Merial-Kieny C,. Impact of Avène hydrotherapy in the quality of life of atopic and psoriatic patients. J Eur Acad Dermatol Venereol 2011; 25: 24-9.
73. Fivenson D, Arnold RJG, Kaniecki DJ, et al,. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organisation. J Managed Care Pharmacy 2002; 8: 333-42.
74. Chuh AA,. Quality of life in children with pityriasis rosea: a prospective case control study. Pediatr Dermatol 2003; 20: 474-8.
75. Charman CR, Venn AJ, Williams HC,. The patient-orientated eczema measure-development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-19.
76. Charman CR, Venn AJ, Williams H,. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol 2005; 141: 1146-51.
77. Beattie PE, Lewis-Jones MS,. A comparative study of impairment of quality of life in children with skin diseases and children with other chronic child diseases. Br J Dermatol 2006; 155: 145-51.
78. El-Mongy S, Ahmed EF, El-Bahaey W,. Atopic dermatitis: relation between disease severity, anxiety and quality of life in children and adults. Egyptian Dermatol Online J 2006; 2: 1-17.
79. Hon KLE, Kam WYC, Lam MCA, et al,. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res 2006; 15: 1551-8.
80. Ganemo A, Svensson A, Lindberg M, Wahlgren CF,. Quality of life in Swedish children with eczema. Acta Derm Venereol 2007; 87: 345-9.
81. Hon KL, Lam MC, Wong KY, et al,. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol 2007; 157: 922-5.
82. Mozaffari H, Pourpak Z, Pourseyed S, et al,. Quality of life in atopic dermatitis patients. J Microbiol Immunol Infect 2007; 40: 260-4.
83. Hon KL, Wong KY, Leung TF, et al,. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 2008; 9: 45-50.
84. Hon KL, Leung TF, Wong KY, et al,. Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol 2008; 33: 705-9.
85. Al-Buainain H, Al Mahmoud K, Allam M,. Correlation between quality of life and disease severity in children with atopic dermatitis in the State of Qatar. Panarab J 2009; 20: 43-9.
86. Kondo Y, Nakajima Y, Komatsubara R, et al,. Short-term efficacy of tacrolimus ointment and impact on quality of life. Paediatr Int 2009; 51: 385-9.
87. Wolkenstein P, Rodriguez D, Ferkal S, et al,. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. Br J Dermatol 2009; 160: 844-8.
88. De Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM,. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: the negative effect on the quality of life and moderate correlation of CDLQI and severity scores. Br J Dermatol 2010; 163: 1099-101.
89. Ganemo A,. Quality of life in Swedish children with congenital ichthyosis. PagePress (online) 2010; 2: 1.
90. Lam KM,. Quality of life assessment among patients with atopic eczema attending dermatology clinics in Hong Kong. Hong Kong J Dermatol Venereol 2010; 18: 181-8.
91. Pavlis MB, Rice ZP, Veledar E, et al,. Quality of life of cutaneous disease in the ectodermal dysplasias. Pediatr Dermatol 2010; 27: 260-5.
92. Farina S, Gisondi P, Zanoni M, et al,. Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. J Dermatolog Treat 2011; 22: 366-71.
93. Ganemo A, Wahlgren C, Svensson A,. Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol 2011; 28: 375-9.
94. Hassab-El-Naby, Hussein MM, Mohamed YF, et al,. Assessment of quality of life among school children with atopic dermatitis in a locality in Cairo. J Egyptian Women's Dermatol Soc 2011; 8: 7-10.
95. Hon KL, Ching GK, Ng PC, Leung TF,. Exploring CCL18, eczema severity and atopy. Pediatr Allergy Immunol 2011; 22: 704-7.
96. Kim KH, Kono T,. Overview of efficacy and safety of tacrolimus ointment in patients with atopic dermatitis in Asia and other areas. Int J Dermatol 2011; 50: 1153-61.
97. Monti F, Agostini F, Gobbi F, et al,. Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr 2011; 37: 59.
98. Weber MB, Lorenzini D, Reinehr CPH, Lovato B,. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol. 2012; 87: 697-702.
99. Amaral CS, March MP, Sant'Anna CC,. Quality of life in children and teenagers with atopic dermatitis. An Bras Dermatol 2012; 87: 717-23.
100. Jirakova A, Vojackova N, Göpfertova D, Hercogova J,. A comparative study of the impairment of quality of life in Czech children with atopic dermatitis of different age groups and their families. Int J Dermatol 2012; 51: 688-92.
101. Kim DH, Li K, Seo SJ, et al,. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci 2012; 27: 1327-32.
102. Pei AYS, Chan HH, Leung TF,. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol 2001; 12: 154-8.
103. Hon KL, Wang SS, Hung EC, et al,. Serum levels of heavy metals in childhood eczema and skin diseases: friends or foes. Pediatr Allergy Immunol 2010; 21: 831-6.
104. Hon K, Wong K, Cheung L, et al,. Efficacy and problems associated with a wet-wrap garment for children with severe atopic dermatitis. J Dermatolog Treat 2007; 18: 301-5.
105. Ching GK, Hon KL, Ng PC, Leung TF,. Filaggrin null mutations in childhood atopic dermatitis among the Chinese. Int J Immunogenet 2009; 36: 251-4.
106. Schmitt J, Meurer M, Schwanebeck U, et al,. Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. Dermatology 2008; 217: 299-308.
107. Manzoni APDS, Pereira RL, Townsend RZ, et al,. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases. An Bras Dermatol. 2012; 87: 361-8.
108. Weber MB, Fontes Neto Pde T, Prati C,. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol 2008; 22: 992-7.
109. Lara-Corrales I, Parkin PC, Stephens D, et al,. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial. J Am Acad Dermatol 2012; 66: 264-70.
110. Hon KL, Ching GK, Leung TF, et al,. Estimating emollient usage in patients with eczema. Clin Exp Dermatol 2010; 35: 22-6.
111. Hon KL, Chan IH, Chow CM, et al,. Specific IgE of common foods in Chinese children with eczema. Pediatr Allergy Immunol 2011; 22: 50-3.
112. Hon KL, Wang SS, Pong NHH, Leung TF,. Circulating immunoglobulins, leucocytes and complements in childhood-onset atopic eczema. Indian J Pediatr 2013; 80: 128-31.
113. Hon KL, Wang SS, Leung T,. The atopic march: from skin to the airways. Iran J Allergy Asthma Immunol 2012; 11: 73-7.
114. Holm EA, Esmann S, Jemec GB,. Patient education and morbidity in atopic eczema. Dermatol. Nurs 2005; 17: 35-46.
115. Fotiadou C, Lazaridou E, Giannopoulou C, Ioannides D,. Ustekinumab for the treatment of an adolescent patient with recalcitrant plaque psoriasis. Eur J Dermatol 2011; 21: 117-18.
116. De Jager ME, De Jong EM, Evers AW, et al,. The burden of childhood psoriasis. Pediatr Dermatol 2011; 28: 736-7.
117. Horn HM, Tidman MJ,. Quality of life in epidermolysis bullosa. Clin Exp Dermatol 2002; 27: 707-10.
118. Canter PH, Brown LB, Greaves C, Ernst E,. Johrei family healing: a pilot study. Evid Based Complement Alternat Med 2006; 3: 533-40.
119. Holme SA, Anstey AV, Finlay AY,. Erythropoietic protoporphyria in the UK: clinical features and effect on quality of life. Br J Dermatol 2006; 155: 574-81.
120. Rizwan M, Haylett AK, Richards HL, et al,. Impact of photosensitivity disorders on the life quality of children. Photodermatol Photoimmunol Photomed 2012; 28: 290-2.
121. Keibert G, Sorensen SV, Revicki D, et al,. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151-8.
122. Huggins RH, Leithauser LA, Eide MJ, et al,. Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatol Photoimmunol Photomed 2009; 25: 209-15.
123. Orzechowski NM, Davis DM, Mason TG, et al,. Health-related quality of life in children and adolescents with juvenile localised scleroderma; medical and economic results. Rheumatology (Oxford) 2009; 48: 670-2.
124. Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr,. Development and initial validation of the localised scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 2010; 49: 373-81.
125. Hawkins DM, Eide MJ, Lim HW,. Perception of xeroderma pigmentosum support group members of xeroderma pigmentosum lifestyle impact. Photodermatol Photoimmunol Photomed 2012; 28: 338-9.
126. Bieber T, Vick K, Folster-Holst R, et al,. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184-9.
127. Peserico A, Städtler G, Sebastian M, et al,. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008; 158: 801-7.
128. Hon KL, Ching GK, Wong KY, et al,. A pilot study to explore the usefulness of antibody array in childhood atopic dermatitis. J Natl Med Assoc 2008; 100: 500-4.